SCHEMBL294547

SCHEMBL294547

C=[C]C(=O)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4337580 0.79
SCHEMBL8561684 0.79
SCHEMBL288480 0.77 ALDH1A1 (0.53)
SCHEMBL18446 0.77 ALDH1A1 (0.53)
SCHEMBL5322592 0.75
SCHEMBL733363 0.74
SCHEMBL3029208 0.74
SCHEMBL9748858 0.74
SCHEMBL4630435 0.74 NAAA (0.52)
SCHEMBL2948744 0.72 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108113895-A Cosmetic foam containing UV filter from emulsion containing sodium cetearyl sulfate and glyceryl monostearate 拜尔斯道夫股份有限公司 2018-06-05 CN claimed
CN-106983671-A Sunscreen agents containing titanium dioxide 拜尔斯道夫股份有限公司 2017-07-28 CN claimed
CN-106456495-A Sunscreen formulations with reduced tendency to stain fabrics III 拜尔斯道夫股份有限公司 2017-02-22 CN claimed
US-9073956-B1 Dihydro-1H-phosphole 1-oxide derivatives and preparation method thereof KNU-INDUSTRY COOPERATION FOUNDATION (KR) 2015-07-07 US claimed
EP-2517709-A1 MEDICAL AND PHARMACEUTICAL USE OF 2', 2-BIS-THIAZOLE NON-NUCLEOSIDE COMPOUNDS AS HEPATITIS C VIRUS INHIBITOR Shanghai Institute of Materia Medica (CN) 2012-10-31 EP claimed
US-20120264793-A1 Pharmaceutical Use of 2',2-Bis-Thiazole Non-Nucleoside Compounds as Hepatitis C Virus Inhibitor SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2012-10-18 US claimed
EP-1454903-B9 Thiadiazoline derivatives for treating cancer KYOWA HAKKO KIRIN CO LTD (JP) 2011-10-05 EP claimed
EP-1454903-B1 Thiadiazoline derivatives for treating cancer KYOWA HAKKO KIRIN CO LTD (JP) 2010-09-08 EP claimed
US-20100056569-A1 Heterocyclic Non-Nucleoside Compounds, Their Preparation, Pharmaceutical Composition And Their Use As Antiviral Agents SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2010-03-04 US claimed
EP-2030974-A1 HETEROCYCLIC NON-NUCLEOSIDE COMPOUNDS, THEIR PEPARATION, PHARMACEUTICAL COMPOSITION AND THEIR USE AS ANTIVIRAL AGENTS Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2009-03-04 EP claimed
EP-0785938-A1 FUSED PYRROLOCARBAZOLES CEPHALON, INC. (US) 1997-07-30 EP claimed
JP-2633087-B2 1997-07-23 JP claimed
US-5594009-A KINASE INHIBITORS, TROPHIC FACTOR-INDUCED ACTIVITY ENHANCEMENT, CELL SURVIVAL CEPHALON, INC. (US) 1997-01-14 US claimed
US-5591855-A KINASE INHIBITORS, TROPHIC FACTOR-INDUCED ACTIVITY ENHANCEMENT, CELL SURVIVAL CEPHALON, INC. (US) 1997-01-07 US claimed
WO-1996011933-A1 FUSED PYRROLOCARBAZOLES CEPHALON, INC. (US) 1996-04-25 WO claimed
EP-0618907-A1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS Knoll AG (DE) 1994-10-12 EP claimed
WO-1993013075-A1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS THE BOOTS COMPANY PLC (GB) 1993-07-08 WO claimed
EP-0204534-A2 Quinazolinone compounds and processes for the preparation thereof TANABE SEIYAKU CO., LTD. (JP) 1986-12-10 EP claimed
US-4174445-A INSECTICIDES BAYER AKTIENGESELLSCHAFT (DE) 1979-11-13 US claimed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP claimed